Skip to main content
Defense Acquisition

GAO Faults FDA IT Modernization Over Investment Tracking and Risk Mitigation

The Government Accountability Office found that while the Food and Drug Administration established a comprehensive IT modernization framework, the agency lacks critical mechanisms to monitor risk mitigation and link major capital investments to strategic mission goals, threatening digital transformation oversight.

November 19, 2026·2 min read·Updated November 20, 2026·Analysis·By Defense Signals Desk·Sourced intelligence·
Signal Intelligence™ · generating Executive Brief

The Food and Drug Administration’s multi-year effort to modernize its digital architecture faces structural governance and oversight gaps, according to a Government Accountability Office report. While the agency established baseline strategic documentation addressing six of eight leading federal practices, it failed to fully operationalize risk mitigation monitoring or formally link major IT capital investments to broader strategic objectives. The review, mandated by the Consolidated Appropriations Act of 2023, underscores persistent cross-agency friction in translating high-level modernization roadmaps into disciplined, measurable portfolio execution.

GAO evaluated five of the FDA’s largest IT investments, revealing uneven performance tracking across mission-critical systems. Although the agency developed metrics aligned with strategic goals and tracked performance data for most initiatives, it failed to demonstrate how performance data was actively used to manage and remediate execution for at least one major program. For federal acquisition officers and agency CIOs, this disconnect highlights an ongoing systemic vulnerability: gathering compliance metrics without integrating them into real-time program governance, capital allocation, and contract adjustment cycles.

The findings carry direct implications for defense, civilian health, and national security leaders managing complex IT acquisitions. The FDA’s regulatory purview intersects directly with biological defense, medical countermeasures, counter-CBRN supply chain tracing, and federal medical logistics. A modernization plan that fails to clearly connect IT investments with strategic milestones increases the likelihood of schedule slippage, budget overruns, and fractured data interoperability with interagency partners like the Defense Health Agency and the Administration for Strategic Preparedness and Response. Federal program managers must enforce tight linkage between capital investment decisions and quantifiable operational outcomes to prevent program atrophy.

For defense and federal contractors, the GAO review signals tightening oversight on IT modernization task orders. As Congress and federal watchdogs increase scrutiny on federal software and infrastructure investments, agencies will face heightened pressure to establish rigorous baseline traceability and show that contracted systems deliver measurable performance improvements. Systems integrators and vendors supporting federal digital transformation should prepare for elevated demand for automated portfolio management tools, objective milestone verification, and auditable risk mitigation architectures to satisfy federal capital planning requirements. (Source: GAO Reports)

Executive takeaway

Subscribe to receive signals like this — plus the executive analysis behind them.

Get the Signals